XML 22 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Follow-on Public Offering
At-the-market Offering
Common Stock
Common Stock
Follow-on Public Offering
Common Stock
At-the-market Offering
Additional Paid-In Capital
Additional Paid-In Capital
Follow-on Public Offering
Additional Paid-In Capital
At-the-market Offering
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2021 $ 301,514     $ 4     $ 478,970     $ (712) $ (176,748)
Beginning balance, shares at Dec. 31, 2021       38,533,045              
Issuance of common stock, net of issuance cost   $ 86,081 $ 8,842   $ 1     $ 86,080 $ 8,842    
Issuance of common stock, net of issuance costs, shares         8,761,905 601,844          
Issuance of common stock upon exercise of stock options 1,448           1,448        
Issuance of common stock upon exercise of stock options, shares       214,643              
Employee stock purchase plan (ESPP) purchase 755           755        
Employee stock purchase plan (ESPP) purchase, shares       81,742              
Stock-based compensation 11,629           11,629        
Other comprehensive gain (loss) (2,159)                 (2,159)  
Net Income (Loss) (58,655)                   (58,655)
Ending balance at Dec. 31, 2022 349,455     $ 5     587,724     (2,871) (235,403)
Ending balance, shares at Dec. 31, 2022       48,193,179              
Issuance of common stock, net of issuance cost   281,122 28,598   $ 2     281,120 28,598    
Issuance of common stock, net of issuance costs, shares         14,655,993 1,188,705          
Issuance of pre-funded warrants for the purchase of common stock 42,182           42,182        
Issuance of common stock upon exercise of stock options 9,559           9,559        
Issuance of common stock upon exercise of stock options, shares       931,012              
Employee stock purchase plan (ESPP) purchase 1,213           1,213        
Employee stock purchase plan (ESPP) purchase, shares       70,480              
Stock-based compensation 18,489           18,489        
Other comprehensive gain (loss) 3,433                 3,433  
Net Income (Loss) (112,961)                   (112,961)
Ending balance at Dec. 31, 2023 621,090     $ 7     968,885     562 (348,364)
Ending balance, shares at Dec. 31, 2023       65,039,369              
Issuance of common stock, net of issuance cost   $ 274,350 $ 379,866   $ 1 $ 1   274,349 $ 379,865    
Issuance of common stock, net of issuance costs, shares         8,355,714 10,182,382          
Issuance of pre-funded warrants for the purchase of common stock 9,400             $ 9,400      
Exercise of pre-funded warrants       1,749,993              
Issuance of common stock upon exercise of stock options 12,483           12,483        
Issuance of common stock upon exercise of stock options, shares       1,118,695              
Employee stock purchase plan (ESPP) purchase 1,439           1,439        
Employee stock purchase plan (ESPP) purchase, shares       57,356              
Stock-based compensation 34,746           34,746        
Other comprehensive gain (loss) 250                 250  
Net Income (Loss) (274,477)                   (274,477)
Ending balance at Dec. 31, 2024 $ 1,059,147     $ 9     $ 1,681,167     $ 812 $ (622,841)
Ending balance, shares at Dec. 31, 2024       86,503,509